Autologous bone marrow cell transplantation improves left ventricular function in rabbit hearts with cardiomyopathy via myocardial regeneration-unrelated mechanisms

Heart and Vessels

Volumn 21, Issue 3, 2006, Pages 180-187

  Lu, Chuanjiang ^a   Arai, Masazumi ^a   Misao, Yu ^a   Chen, Xuehai ^a   Wang, Ningyuan ^a   Onogi, Hirohito ^a   Kobayashi, Hiroyuki ^a   Uno, Yoshihiro ^a   Takemura, Genzou ^a   Minatoguchi, Shinya ^a   Fujiwara, Takako ^b   Fujiwara, Hisayoshi ^a  

^a GIFU UNIVERSITY   (Japan)

^b KYOTO WOMEN'S UNIVERSITY   (Japan)

Author keywords

Bone marrow cell transplantation; Cardiomyopathy; Left ventricular function; Myocardial infarction

Indexed keywords

BUFFER; DOXORUBICIN; INTERSTITIAL COLLAGENASE; PHOSPHATE; SODIUM CHLORIDE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BODY WEIGHT; CARDIOMYOPATHY; CONTROLLED STUDY; DOWN REGULATION; ECHOCARDIOGRAPHY; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE WALL; HEART MUSCLE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; ISOLATED HEART; MUSCLE REGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; UPREGULATION;

ANIMALS; BLOOD VESSELS; BONE MARROW TRANSPLANTATION; CARDIOMYOPATHIES; DOXORUBICIN; IMMUNOHISTOCHEMISTRY; MICROSCOPY, CONFOCAL; RABBITS; RECOVERY OF FUNCTION; REGENERATION; STROKE VOLUME; TUMOR NECROSIS FACTOR-ALPHA; VENTRICULAR FUNCTION, LEFT;

EID: 33646719879     PISSN: 09108327     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00380-005-0886-9     Document Type: Article

References (29)

1. T Asahara T Murohara A Sullivan M Silver R Van der Zee T Li B Witzenbichler G Schatteman JM Isner 1997 Isolation of putative progenitor endothelial cells for angiogenesis Science 275 964-967 9020076 1:CAS:528:DyaK2sXht1Clu7k%3D 10.1126/science.275.5302.964
2. D Orlic J Kajstura S Chimenti I Jakoniuk SM Anderson B Li J Pickel R McKay B Nadal-Ginard DM Bodine A Leri P Anversa 2001 Bone marrow cells regenerate infarcted myocardium Nature 410 701-705 11287958 1:CAS:528:DC%2BD3MXivFSmsb4%3D 10.1038/35070587
3. JS Wang D Shum-Tim E Chedrawy RC Chiu 2001 The coronary delivery of marrow stromal cells for myocardial regeneration: Pathophysiologic and therapeutic implications J Thorac Cardiovasc Surg 122 699-705 11581601 1:STN:280:DC%2BD3MrjsVeltg%3D%3D 10.1067/mtc.2001.116317
4. KA Jackson SM Majka H Wang J Pocius CJ Hartley MW Majesky ML Entman LH Michael KK Hirschi MA Goodell 2001 Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells J Clin Invest 107 1395-1402 11390421 1:CAS:528:DC%2BD3MXktFynt7o%3D
5. D Orlic J Kajstura S Chimenti F Limana I Jakoniuk F Quiani B Nadal-Ginard DM Bodine A Leri P Anversa 2001 Mobilized bone marrow cells repair the infarcted heart, improving function and survival Proc Natl Acad Sci USA 98 10344-10349 11504914 1:CAS:528:DC%2BD3MXmvFWiu7w%3D 10.1073/pnas.181177898
6. H Kawabata T Ryomoto K Ishikawa 2001 Effect of beta-blocker on metabolism and contraction of doxorubicin-induced cardiotoxicity in the isolated perfused rabbit heart Angiol 51 405-413
7. L Arnolda B McGrath M Cocks E Sumithran C Johnston 1985 Adriamycin cardiomyopathy in the rabbit: An animal model of low output cardiac failure with activation of vasoconstrictor mechanisms Cardiovasc Res 19 378-382 4016815 1:CAS:528:DyaL2MXltlClsLY%3D
8. O Agbulut ML Menot Z Li F Marotte D Paulin AA Hagege C Chomienne JL Samuel P Menasche 2003 Temporal patterns of bone marrow cells differentiation following transplantation in doxorubicin-induced cardiomyopathy Cardiovasc Res 58 451-459 12757879 1:CAS:528:DC%2BD3sXjvFagurg%3D 10.1016/S0008-6363(03)00281-5
9. Z Gunja-Smith AR Morales R Romanelli JF Woessner 1996 Remodeling of human myocardial collagen in idiopathic dilated cardiomyopathy Am J Pathol 148 1639-1648 8623931 1:STN:280:BymB3cfhtlw%3D
10. Y Iwanaga T Aoyama Y Kihara Y Onozawa T Yoneda S Sasayama 2002 Excessive activation of matrix metalloproteinases coincides with left ventricular remodeling during transition from hypertrophy to heart failure in hypertensive rats J Am Coll Cardiol 39 1384-1391 11955860 1:CAS:528:DC%2BD38XjsFait7w%3D 10.1016/S0735-1097(02)01756-4
11. SC Tyagi S Kumar DJ Voelker HK Reddy JS Janicki JJ Curtis 1996 Differential gene expression of extracellular matrix components in dilated cardiomyopathy J Cell Biochem 63 185-198 8913870 1:CAS:528:DyaK28XmslGju7s%3D 10.1002/ (SICI)1097-4644(19961101)63:2<185::AID-JCB6>3.0.CO;2-U
12. CV Thomas ML Coker JL Zellner JR Handy AJ Crumbley FG Spinale 1998 Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy Circulation 97 1708-1715 9591765 1:STN:280:DyaK1c3lt1Cguw%3D%3D
13. ML Coker CV Tomas MJ Clair JW Hendrick RS Krombach ZS Galis FG Spinale 1998 Myocardial matrix metalloproteinase activity and abundance with congestive heart failure Am J Physiol 274 H1515-H1523
14. P Bai JG Mabley L Liaudet L Virag C Szabo P Pacher 2004 Matrix metalloproteinase activation is an early event in doxorubicin-induced cardiotoxicity Oncol Rep 11 505-508 14719091 1:CAS:528:DC%2BD2cXhsVGksb4%3D
15. HE Kim SS Dalal E Young MJ Legato ML Weisfeldt J D'Armiento 2000 Disruption of the myocardial extracellular matrix leads to cardiac dysfunction J Clin Invest 106 857-866 11018073 1:CAS:528:DC%2BD3cXntVyiu7k%3D
16. JT Peterson H Hallak L Johnson H Li PM O'Brien DR Sliskovic TM Bocan ML Coker T Etoh FG Spinale 2001 Matrix metalloproteinase inhibition attenuates left ventricular remodeling and dysfunction in a rat model of progressive heart failure Circulation 103 2303-2309 11342481 1:CAS:528:DC%2BD3MXkt1GntLw%3D
17. FG Spinale ML Coker BR Bond JL Zellner 2000 Myocardial matrix degradation and metalloproteinase activation in the failing heart: A potential therapeutic target Cardiovasc Res 46 225-238 10773226 1:CAS:528:DC%2BD3cXisFGru7o%3D 10.1016/S0008-6363(99)00431-9
18. FG Spinale ML Coker SR Krombach R Mukherjee H Hallak WV Houck MJ Clair SB Kribbs LL Johnson JT Peterson MR Zile 1999 Matrix metalloproteinase inhibition during the development of congestive heart failure: Effects on left ventricular dimensions and function Circ Res 85 364-376 10455065 1:CAS:528:DyaK1MXltlehurk%3D
19. YY Li T Kadokami P Wang CF McTiernan AM Feldman 2002 MMP inhibition modulates TNF-α transgenic mouse phenotype early in the development of heart failure Am J Physiol 282 H983-H989 1:CAS:528:DC%2BD38Xit1Ghu74%3D
20. H Chen D Li T Saldeen JL Mehta 2003 TGF-β1 attenuates myocardial ischemia-reperfusion injury via inhibition of upregulation of MMP-1 Am J Physiol 284 H1612-1617 1:CAS:528:DC%2BD3sXjvFGrt7w%3D
21. MC Warren EA Bump D Medeiros SJ Braunhut 2000 Oxidative stress-induced apoptosis of endothelial cells Free Radic Biol Med 29 537-547 11025197 1:CAS:528:DC%2BD3cXnt1Sisr8%3D 10.1016/S0891-5849(00)00353-1
22. GF Baxter MM Mocanu BK Brar DS Latchman DM Yellon 2001 Cardioprotective effects of transforming growth factor-betal during early reoxygenation or reperfusion are mediated by p42/p44 MAPK J Cardiovasc Pharmacol 38 930-939 11707697 1:CAS:528:DC%2BD3MXovVOnsbk%3D 10.1097/ 00005344-200112000-00015
23. AM Lefer P Tsao N Aoki MA Palladino 1990 Mediation of cardioprotection by transforming growth factor-β Science 249 61-64 2164258 1:CAS:528:DyaK3cXkslWrurY%3D
24. WS Bradham G Moe KA Wendt AA Scott A Konig M Romanova G Naik FG Spinale 2002 TNF-α and myocardial matrix metalloproteinases in heart failure: Relationship to LV remodeling Am J Physiol 282 H1288-H1295 1:CAS:528:DC%2BD38XivVent7s%3D
25. YY Li YQ Feng T Kadokami CF McTiernan R Draviam SC Watkins AM Feldman 2000 Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis α can be modulated by anti-tumor necrosis factor α therapy Proc Natl Acad Sci USA 97 12746-12751 11070088 1:CAS:528:DC%2BD3cXotFyntL4%3D 10.1073/pnas.97.23.12746
26. N Sivasubramanian ML Coker KM Kurrelmeyer WR MacLellan FJ DeMayo FG Spinale 2001 Left ventricular remodeling in transgenic mice with cardiac restricted overexpression of tumor necrosis factor Circulation 104 826-831 11502710 1:CAS:528:DC%2BD3MXmsVOguro%3D
27. D Bryant L Becker J Richardson J Shelton F Franco R Peshock M Thompson B Giroir 1998 Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-α Circulation 97 1375-1381 9577949 1:CAS:528:DyaK1cXis1KqtLw%3D
28. A Deswal B Bozkurt Y Seta S Parilti-Eiswirth F Hayes C Blosch DL Mann 1999 Safety and efficacy of a soluble p75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advance heart failure Circulation 99 3224-3226 10385494 1:CAS:528:DyaK1MXksVaqu70%3D
29. JH Doroshow C Tallent JE Schechter 1985 Ultrastructural features of Adriamycin-induced skeletal and cardiac muscle toxicity Am J Pathol 118 288-297 3970141 1:CAS:528:DyaL2MXhs1Sisb8%3D